Want to see TSE:ZRO full AI Analyst Report?
Biosenta Inc (ZRO) Ratios
Biosenta Inc Ratios
TSE:ZRO's free cash flow for Q3 2026 was $-110.44K. For the 2026 fiscal year, TSE:ZRO's free cash flow was increased by $0.00 and operating cash flow was $-110.44K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.04 | 0.03 | 0.08 | 0.09 |
| Quick Ratio | 0.00 | 0.02 | 0.02 | 0.07 | 0.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
| Solvency Ratio | -0.25 | -0.28 | -0.60 | -0.08 | -0.72 |
| Operating Cash Flow Ratio | -0.05 | -0.31 | -0.21 | -0.16 | -0.24 |
| Short-Term Operating Cash Flow Coverage | -0.72 | -8.06 | -1.70 | -14.51 | -7.27 |
| Net Current Asset Value | $ -10.10M | $ -7.89M | $ -7.87M | $ -2.92M | $ -2.59M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 6.30 | 48.90 | 52.22 | 0.37 | 0.58 |
| Debt-to-Equity Ratio | -0.07 | -0.70 | -0.72 | -0.03 | -0.06 |
| Debt-to-Capital Ratio | -0.07 | -2.39 | -2.51 | -0.03 | -0.06 |
| Long-Term Debt-to-Capital Ratio | -0.01 | -2.25 | -2.07 | -0.02 | -0.02 |
| Financial Leverage Ratio | -0.01 | -0.01 | -0.01 | -0.09 | -0.10 |
| Debt Service Coverage Ratio | -0.79 | -0.88 | -16.08 | -4.90 | -19.79 |
| Interest Coverage Ratio | -1.19 | -1.04 | -23.46 | -5.42 | -197.06 |
| Debt to Market Cap | 0.17 | 2.14 | 0.51 | 0.01 | 0.02 |
| Interest Debt Per Share | 0.05 | 0.23 | 0.22 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.48 | -5.09 | -0.90 | -0.05 | -0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | -146.74% | 60.55% | 40.98% | 63.25% | 58.96% |
| EBIT Margin | -114714.29% | -79242.35% | -598405.85% | -107331.28% | -1208.54% |
| EBITDA Margin | -114520.73% | -79030.17% | -598405.85% | -107331.28% | -1208.54% |
| Operating Profit Margin | -109577.21% | -85914.36% | -144909.98% | -104977.93% | -1201.41% |
| Pretax Profit Margin | -206924.36% | -161543.00% | -604582.92% | -126695.13% | -1214.64% |
| Net Profit Margin | -206924.36% | -161543.00% | -604582.92% | -126695.13% | -1220.74% |
| Continuous Operations Profit Margin | -206924.36% | -161543.00% | -604582.92% | -126695.13% | -1214.64% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.50% |
| EBT Per EBIT | 188.84% | 188.03% | 417.21% | 120.69% | 101.10% |
| Return on Assets (ROA) | -2271.15% | -1961.99% | -5855.23% | -569.46% | -778.31% |
| Return on Equity (ROE) | 24.90% | 28.29% | 80.19% | 49.86% | 79.12% |
| Return on Capital Employed (ROCE) | 13.26% | 48.95% | 58.98% | 42.18% | 79.71% |
| Return on Invested Capital (ROIC) | 14.16% | 50.99% | 67.50% | 42.79% | 82.72% |
| Return on Tangible Assets | -2271.15% | -1961.99% | -5855.23% | -569.46% | -778.31% |
| Earnings Yield | -62.78% | -86.00% | -57.37% | -17.11% | -21.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.12 | 0.03 | 0.05 | 0.01 | 53.93 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Inventory Turnover | 0.08 | 0.01 | 0.02 | 0.01 | 0.89 |
| Fixed Asset Turnover | 0.03 | 0.11 | 0.07 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.00 | 0.64 |
| Working Capital Turnover Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.08 |
| Cash Conversion Cycle | -166712.03 | -848572.02 | -696373.67 | -564484.73 | -2625.55 |
| Days of Sales Outstanding | 3122.54 | 12305.98 | 7176.00 | 46023.93 | 6.77 |
| Days of Inventory Outstanding | 4559.57 | 25647.29 | 23516.09 | 38982.52 | 407.89 |
| Days of Payables Outstanding | 174394.14 | 886525.28 | 727065.76 | 649491.18 | 3040.21 |
| Operating Cycle | 7682.11 | 37953.27 | 30692.09 | 85006.45 | 414.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -17.61 | 0.00 | -35.40 | 0.00 | -224095.67 |
| Capital Expenditure Coverage Ratio | -17.61 | 0.00 | -35.40 | 0.00 | -224095.67 |
| Operating Cash Flow Coverage Ratio | -0.66 | -0.14 | -0.10 | -5.32 | -4.41 |
| Operating Cash Flow to Sales Ratio | -376.03 | -565.15 | -528.59 | -438.26 | -4.00 |
| Free Cash Flow Yield | -12.06% | -30.09% | -5.16% | -5.92% | -7.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.59 | -1.16 | -1.74 | -5.84 | -4.60 |
| Price-to-Sales (P/S) Ratio | 3296.23 | 1878.41 | 10539.14 | 7403.47 | 56.11 |
| Price-to-Book (P/B) Ratio | -0.40 | -0.33 | -1.40 | -2.91 | -3.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.29 | -3.32 | -19.39 | -16.89 | -14.03 |
| Price-to-Operating Cash Flow Ratio | -8.77 | -3.32 | -19.94 | -16.89 | -14.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.59 | 0.02 | -0.01 | 0.15 | -0.04 |
| Enterprise Value Multiple | -3.36 | -7.46 | -2.66 | -6.95 | -4.66 |
| Enterprise Value | 4.66M | 8.13M | 16.59M | 8.59M | 9.47M |
| EV to EBITDA | -3.36 | -7.46 | -2.66 | -6.95 | -4.66 |
| EV to Sales | 3847.92 | 5898.20 | 15925.90 | 7462.12 | 56.35 |
| EV to Free Cash Flow | -9.68 | -10.44 | -29.30 | -17.03 | -14.09 |
| EV to Operating Cash Flow | -10.23 | -10.44 | -30.13 | -17.03 | -14.09 |
| Tangible Book Value Per Share | -0.30 | -0.27 | -0.30 | -0.14 | -0.15 |
| Shareholders’ Equity Per Share | -0.30 | -0.27 | -0.30 | -0.14 | -0.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Income Per Share | -0.08 | -0.08 | -0.24 | -0.07 | -0.12 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.01 |
| Interest Burden | 1.80 | 2.04 | 1.01 | 1.18 | 1.01 |
| Research & Development to Revenue | 27.68 | 29.96 | 64.00 | 89.53 | 0.48 |
| SG&A to Revenue | 1066.62 | 827.67 | 1363.89 | 951.99 | 11.82 |
| Stock-Based Compensation to Revenue | 262.37 | 45.83 | 161.83 | 97.62 | 5.31 |
| Income Quality | 0.18 | 0.35 | 0.09 | 0.35 | 0.33 |
Currency in CAD
